Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis
Open Access
- 12 November 2021
- journal article
- review article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 09 (11) , E1740-E1751
Abstract
Background and study aims Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) are new endoscopic procedures for patients with gastroesophageal reflux disease (GERD). We conducted a meta-analysis to systematically assess the feasibility, clinical success, and safety of these procedures. Patients and methods We searched Embase, PubMed, and Cochrane Central from inception to October 2020. Overlapping reports, animal studies, and case reports were excluded. Our primary outcomes were clinical success and adverse events (AEs). Secondary outcomes included technical success, endoscopic esophagitis, 24-hour pH monitoring, and proton pump inhibitor (PPI) use. A random effects model was used to pool data. Results In total, 15 nonrandomized studies (12 ARMS, n = 331; 3 ARMA, n = 130) were included; 10 were conducted in patients with refractory GERD. The technical success rate was 100 %. The pooled short-term (first assessment within the first 6 months), 1-year, and 3-year clinical success rates were 78 % (95 % confidence interval [95 %CI] 70 %–85 %), 72% (95 %CI 47 %–92 %), and 73 % (95 %CI 65 %–81 %), respectively. ARMS and ARMA yielded similar clinical success. The proportion of patients off PPIs at 1 year was 64 % (95 %CI 52 %–75 %). There were significant drops (P < 0.01) in validated clinical questionnaires scores, presence of esophagitis, and acid exposure time. The most common AE (11 %, 95 %CI 8 %–15 %) was dysphagia requiring dilation (7%, 95 %CI 5 %–11 %). Four cases of perforation were recorded, all in patients undergoing ARMS. Conclusions Our meta-analysis of nonrandomized studies suggests that ARMS and ARMA are safe and effective for patients with GERD.Keywords
This publication has 27 references indexed in Scilit:
- Primary and Redo Antireflux Surgery: Outcomes and Lessons LearnedJournal of Gastrointestinal Surgery, 2017
- Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux diseaseSurgical Endoscopy, 2017
- Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysisGut, 2017
- Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología DigestivaRevista Española de Enfermedades Digestivas, 2016
- Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adultsCochrane Database of Systematic Reviews, 2015
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Medical Research Methodology, 2014
- A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux diseaseScandinavian Journal of Gastroenterology, 2014
- Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study2014
- Meta-analysis of prevalenceJournal of Epidemiology and Community Health, 2013
- Meta‐analysis: the effects of placebo treatment on gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2010